Vanguard Discloses 12.1% Stake in IDEXX Labs as of Dec 29, 2023
Ticker: IDXX · Form: SC 13G/A · Filed: Feb 13, 2024 · CIK: 874716
| Field | Detail |
|---|---|
| Company | Idexx Laboratories Inc /De (IDXX) |
| Form Type | SC 13G/A |
| Filed Date | Feb 13, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**Vanguard still owns 12.1% of IDEXX, showing continued institutional confidence.**
AI Summary
The Vanguard Group, a major investment firm, filed an amendment (SC 13G/A) on February 13, 2024, updating its ownership in IDEXX Laboratories Inc. As of December 29, 2023, Vanguard reported beneficial ownership of 10,049,599 shares of IDEXX Common Stock, representing 12.1% of the company's outstanding shares. This filing indicates Vanguard's continued significant, but passive, investment in IDEXX, which is important for investors as large institutional holdings can signal confidence in a company's long-term prospects.
Why It Matters
This filing shows that a major institutional investor, Vanguard, maintains a substantial stake in IDEXX Laboratories, which can be a positive signal for current and prospective shareholders.
Risk Assessment
Risk Level: low — This filing is routine and indicates a stable, passive institutional ownership, posing minimal risk to investors.
Analyst Insight
Investors should note Vanguard's continued substantial, passive ownership in IDEXX, which suggests long-term institutional confidence without indicating any immediate strategic changes.
Key Numbers
- 10,049,599 — Shares Beneficially Owned (Represents the total number of IDEXX Laboratories Inc. Common Stock shares held by The Vanguard Group as of December 29, 2023.)
- 12.1% — Percentage of Class (Indicates the proportion of IDEXX Laboratories Inc.'s Common Stock beneficially owned by The Vanguard Group, signaling a significant institutional stake.)
Key Players & Entities
- The Vanguard Group (company) — reporting person and institutional investor
- IDEXX Laboratories Inc (company) — issuer of the securities
- 10,049,599 shares (dollar_amount) — total shares beneficially owned by Vanguard
- 12.1% (dollar_amount) — percentage of IDEXX's class of securities owned by Vanguard
- December 29, 2023 (date) — date of the event requiring the filing
- February 13, 2024 (date) — filing date of the SC 13G/A
Forward-Looking Statements
- Vanguard will maintain a significant, passive stake in IDEXX Laboratories Inc. for the foreseeable future. (The Vanguard Group) — high confidence, target: December 2024
FAQ
Who filed this SC 13G/A amendment?
This SC 13G/A amendment was filed by The Vanguard Group, as indicated in the 'NAME OF REPORTING PERSON' section of the filing.
What company's securities are the subject of this filing?
The securities are those of IDEXX Laboratories Inc, as stated under 'Name of issuer' and 'COMPANY CONFORMED NAME' in the filing.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 29, 2023, as specified in the filing.
How many shares of IDEXX Laboratories Inc. Common Stock does Vanguard beneficially own according to this filing?
The Vanguard Group beneficially owns 10,049,599 shares of IDEXX Laboratories Inc. Common Stock, as detailed in the filing.
What percentage of IDEXX Laboratories Inc.'s Common Stock does Vanguard own?
The Vanguard Group owns 12.1% of IDEXX Laboratories Inc.'s Common Stock, as reported in the filing.
Filing Stats: 808 words · 3 min read · ~3 pages · Grade level 11.6 · Accepted 2024-02-13 17:06:19
Filing Documents
- tv01165-idexxlaboratoriesinc.htm (SC 13G/A) — 11KB
- 0001104659-24-021167.txt ( ) — 13KB
(a) - Name of Issuer
Item 1(a) - Name of Issuer: IDEXX Laboratories Inc
(b) - Address of Issuer's Principal Executive Offices
Item 1(b) - Address of Issuer's Principal Executive Offices: One IDEXX Drive Westbrook, ME 04092-2040
(a) - Name of Person Filing
Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930
(b) – Address of Principal Business Office or, if none, residence
Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355
(c) – Citizenship
Item 2(c) – Citizenship: Pennsylvania
(d) - Title of Class of Securities
Item 2(d) - Title of Class of Securities: Common Stock
(e) - CUSIP Number
Item 2(e) - CUSIP Number 45168D104
- Type of Filing
Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E).
- Ownership
Item 4 - Ownership: (a) Amount Beneficially Owned: (b) Percent of Class: (c) Number of shares as to which such person has: (i) sole power to vote or direct to vote: (ii) shared power to vote or direct to vote: (iii) sole power to dispose of or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Comments: The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.
- Ownership of Five Percent or Less of a Class
Item 5 - Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following
- Ownership of More Than Five Percent on Behalf of Another Person
Item 6 - Ownership of More Than Five Percent on Behalf of Another Person: The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%. Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: Not applicable
- Identification and Classification of Members of Group
Item 8 - Identification and Classification of Members of Group: Not applicable
- Notice of Dissolution of Group
Item 9 - Notice of Dissolution of Group: Not applicable
- Certification
Item 10 - Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2024 By /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration